MOST asymptomatic individuals infected with HIV-1 have a cytotoxic T l
ymphocyte (CTL) response to the virus Gag proteins which can be demons
trated in vitro(1,2). Epitopes have been mapped in p17 Gag and p24 Gag
restricted by HLA-B8 (p17-3 and p24-13) and -B27 (p24-14)(2,3). Virus
es isolated from patients who make CTL responses to these peptides var
y within the genetic sequences encoding these epitopes and some mutati
ons lead to reduction in killing activity in vitro(4). This mas attrib
uted to either failure of the variant epitope to bind major histocompa
tibility complex class I or failure of T-cell receptors to bind the pr
esented peptide. But peptide variants of class I-restricted epitopes c
ause 'antagonism', that is, the presence of a variant epitope (in the
form of peptide) inhibits normal lysis of targets presenting the origi
nal epitope(5,6). This mirrors similar findings in class II-restricted
systems(7-10). Here we report that naturally occurring variant forms
of p17-3, p24-13 and p24-14 may cause antagonism of CTL lines derived
from the same individuals. The effect is present if the epitopes are d
erived from synthetic peptides and when they are processed from full-l
ength proteins expressed by either recombinant vaccinia constructs or
replicating HIV.